BioSpace News Archive

Real-World Data Showing the Impact of Viz.ai on Stroke Workflow and patient treatment at the 2020 International Stroke Conference

DEVON, Pa., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced the acceptance and presentation details of data being presented at the American Society for Experimental Neurotherapeutics (ASENT) 2020 Meeting. The meeting is being held In Bethesda, MD on March 2 nd through March 5 th , 2020. “These new data are impor

Teladoc Health, Inc., the global leader in virtual care, announced that it will host its Investor Day on Thursday, March 5, 2020, in New York City.

Align Technology, Inc. announced the launch of the ClinCheck “In-Face” Visualization tool for the Invisalign Go system, Align’s innovative tooth movement system designed for general dentists.

NEW YORK, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announces new research from the University of Hawaii John A. Burns School of Medicine further demonstrates the clinical superiority of accurate and direct quantification of intravascular blood volume in critically ill patients compared with ultrasound measurement. The new study was

Randy Kluender, DDS, MS has assumed a full-time position at Georgia School of Orthodontics’ Atlanta campus.

PH10, a Neurosteroid Nasal Spray, Demonstrated Significant Rapid-Onset Antidepressive Benefit versus Placebo, without Psychological Side Effects or Safety Concerns Often Associated with Ketamine-based Therapy

Feb. 20, 2020 13:30 UTC BRISBANE, Calif.--( BUSINESS WIRE )-- Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food allergies, today announced that it will host a conference call on Thursday, February 27, 2020, at 4:30 p.m. ET to discuss its financial results for the quarter and full-year ended December 31, 2019, and recent operational highlights. To access the live call by phone,

Nes-Ziona, Israel, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today announced that the company was selected, for a scientific presentation of two posters: (i) Allocetra-OTS: Early Apoptotic Cells for Immune Homeostasis in Human Stem Cell Transplantation (HSCT) and for the Prevention of Graft Versus Host Disease (GvHD)”, and (ii) “Apoptotic Cells Reprogram Resident Macrophages to Support Chimeric Antigen Receptor (CAR) T

SAN FRANCISCO , Feb. 20, 2020 /PRNewswire/ -- Biocare Medical, a leading provider of innovative, automated immunohistochemistry (IHC) reagents and instrumentation, announces the launch of seven novel IVD IHC antibody markers for clinical diagnostics and research applications. The most recent launch focuses on several immuno-oncology markers, critical in aiding early-stage canc